Investors might want to bet on Exponent (EXPO) , as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this trend might continue with its still improving earnings outlook. The Zacks Consensus Estimate for Exponent has increased 10.35% over the last 30 days, as two estimates have gone higher compared to no negative revisions. For the full year, the earnings estimate of $2.04 per share represents a change of +5.15% ...